Browsing by Yonsei Author : Cho, Byoung Chul

Name:
조병철 [Cho, Byoung Chul]
Department :
College of Medicine - Dept. of Internal Medicine
Y-HRN :
(Yonsei Health Research Network)

Results 1-50 of 156.

This table browses all dspace content
Issue DateTitleYonsei Author(s)Type
2019Characterization of head and neck squamous cell carcinoma arising in young patients: Particular focus on molecular alteration and tumor immunity김은경, 윤선옥, 조병철article
2019Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset조병철article
2019Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models조병철, 표경호article
2019The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer김혜련, 윤홍인, 정인경, 조병철article
2018Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck고윤우, 김진아, 김혜련, 윤선옥, 조병철, 최은창, 홍민희article
2018A Clinical Trial of Combination Neoadjuvant Chemotherapy and Transoral Robotic Surgery in Patients with T3 and T4 Laryngo-Hypopharyngeal Cancer금기창, 김다희, 김세헌, 김혜련, 조남훈, 조병철article
2018Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors조병철article
2018Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies조병철article
2018Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer조병철article
2018Profiling of protein–protein interactions via single-molecule techniques predicts the dependence of cancers on growth-factor receptors조병철article
2018Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study조병철article
2018Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation김대준, 김진아, 김혜련, 박성용, 백순명, 심효섭, 윤미란, 이진구, 이한나, 조병철, 표경호, 홍민희article
2018Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer. 조병철article
2018Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors.김혜련, 심효섭, 조병철, 표경호, 홍민희article
2018Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice.김혜련, 안병철, 조병철, 홍민희article
2018ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma강한나, 김혜련, 윤미란, 조병철, 홍민희article
2018Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types 조병철article
2018Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions조병철article
2017Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma김은경, 김혜련, 윤선옥, 조병철, 허수진article
2017Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study김혜련, 조병철article
2017Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective 김대준, 이익재, 이창걸, 장지석, 조병철, 차지혜article
2017Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer김혜련, 심효섭, 조병철, 차윤진article
2017Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma 박영년, 유정은, 임선민, 조병철article
2017Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer강한나, 김상균, 김성무, 김혜련, 김환, 윤미란, 임선민, 조병철, 표경호article
2017Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis 김지형, 김혜련, 박형순, 심효섭, 이진구, 이창영, 조병철, 차윤진, 허수진, 홍민희article
2017Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.김주항, 김혜련, 심효섭, 임선민, 조병철article
2017Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042)조병철article
2017Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer조병철article
2017Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study 김혜련, 서창옥, 이창걸, 장종희, 조병철article
2017Treatment options for EGFR mutant NSCLC with CNS involvement-Can patients BLOOM with the use of next generation EGFR TKIs?조병철article
2017Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma김은영, 김진아, 김혜련, 백순명, 심효섭, 이진구, 조병철, 홍민희article
2017Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy 김현주, 신성관, 이상길, 이용찬, 이창걸, 조병철article
2017Predictive factors of early distant brain failure after gamma knife radiosurgery alone in patients with brain metastases of non-small-cell lung cancer김혜련, 박용구, 장원석, 장진우, 정현호, 조병철article
2017Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer김혜련, 조병철article
2017Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition김은경, 김한상, 신상준, 정기양, 정민규, 조병철article
2017ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC)조병철article
2017Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs김상우, 김성무, 김혜련, 양인석, 이충근, 조병철article
2017Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer조병철article
2017Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma금기창, 김세헌, 김혜련, 박영민, 조남훈, 조병철article
2017Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers조병철article
2017Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization 김혜련, 심효섭, 이진구, 이창영, 정인경, 조병철, 차윤진, 홍민희article
2017A randomized; phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) (vol 8; pg 15943; 2017) 김주항, 김혜련, 정인경, 조병철article
2016Alteration status and prognostic value of MET in head and neck squamous cell carcinoma 김혜련, 윤선옥, 조병철, 조윤아, 허수진article
2016EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines 김민환, 김주항, 김혜련, 문용화, 백순명, 임선민, 조병철article
2016Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.김혜련, 심효섭, 이창영, 조병철, 차윤진article
2016Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial조병철article
2016Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study김혜련, 조병철article
2016Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy 김혜련, 백순명, 조병철, 표경호article
2016Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative 김은영, 김혜련, 백순명, 심효섭, 임선민, 임승택, 조병철article
2016Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy김주항, 김혜련, 박형순, 이민구, 조병철, 조응혁article

Browse